Genetic Immunity, Inc.

Dermavir

Our lead immunotherapy product in Phase III trial for the treatment of HIV.

learn more
Coviderm

Proposed preclinical and Phase I/II clinical trial to adapt our platform technology to target SARS-CoV-2.

learn more
Cancer

Our clinical research program targeting twenty different cancer types.

learn more
Dermall

Immunotherapy for the treatment of food and pollen allergies.

learn more
Hupaderm

Immunetherapy for the treatment of human papillomavirus infection.

learn more
  • News

    Read the latest, and all archived news, of Genetic Immunity, Inc. here.

    more
  • Trials

    The latest information on our ongoing clinical trials program, including results.

    more
  • Partners

    We work with international partners to deilver our vaccine solutions.

    More
  • Therapies

    We target our vaccine technology to address these therapeutic areas.

    More